Refeyn Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 181

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 9

Refeyn General Information

Description

Developer of optical technology designed to determine the mass of individual molecules in multiple ranges. The company's technology offers quality-control type instruments as well as research tools for measuring a range of biologically relevant concentrations, enabling researchers to perform mass measurement of single molecules in a system, in their native state, without the need for labels.

Contact Information

Website
www.refeyn.com
Formerly Known As
Arago Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 9, Trade City
  • Sandy Lane West
  • Oxford OX4 6FF
  • England, United Kingdom
+44 01865
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Biotechnology
Corporate Office
  • Unit 9, Trade City
  • Sandy Lane West
  • Oxford OX4 6FF
  • England, United Kingdom
+44 01865

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Refeyn Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private Completed Generating Revenue
10. Secondary Transaction - Private 06-Apr-2022 Completed Generating Revenue
9. Early Stage VC (Series B) 06-Apr-2022 Completed Generating Revenue
8. Early Stage VC (Series A) 11-Nov-2020 Completed Generating Revenue
7. Grant 01-Oct-2020 Completed Generating Revenue
6. Grant 31-Oct-2019 Completed Generating Revenue
5. Seed Round 05-Jul-2019 Completed Startup
4. Accelerator/Incubator Completed Startup
3. Seed Round 04-Mar-2019 $3.32M $4.25M Completed Startup
2. Seed Round 15-Aug-2018 $932K $932K Completed Startup
To view Refeyn’s complete valuation and funding history, request access »

Refeyn Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Ordinary
Series A1
Series A1
Series A2
Series A2
Series A1
Ordinary
Ordinary 3,667,700 $0.000131 $0.84 $0.84 1x $0.84 9.13%
Ordinary 1,750,000 $0.000131 $0.53 $0.53 1x $0.53 4.36%
To view Refeyn’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Refeyn Patents

Refeyn Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202418668-D0 Method for measuring interaction kinetics Pending 19-Dec-2024
WO-2026132808-A1 Method for measuring interaction kinetics Pending 19-Dec-2024
GB-202418680-D0 Surface generation Pending 19-Dec-2024
WO-2026132807-A1 Surface generation Pending 19-Dec-2024
GB-202400480-D0 Improvements in or relating to single particle light scattering Inactive 12-Jan-2024 G01N15/0211
To view Refeyn’s complete patent history, request access »

Refeyn Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Refeyn Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Foresight Group Asset Manager Minority
Horizons Ventures Venture Capital Minority
Northpond Ventures Venture Capital Minority
Innovate UK Government
Royal Society of Chemistry Government
You’re viewing 5 of 9 investors. Get the full list »

Refeyn FAQs

  • When was Refeyn founded?

    Refeyn was founded in 2018.

  • Where is Refeyn headquartered?

    Refeyn is headquartered in Oxford, United Kingdom.

  • What is the size of Refeyn?

    Refeyn has 181 total employees.

  • What industry is Refeyn in?

    Refeyn’s primary industry is Discovery Tools (Healthcare).

  • Is Refeyn a private or public company?

    Refeyn is a Private company.

  • What is Refeyn’s current revenue?

    The current revenue for Refeyn is .

  • How much funding has Refeyn raised over time?

    Refeyn has raised $115M.

  • Who are Refeyn’s investors?

    Foresight Group, Horizons Ventures, Northpond Ventures, Innovate UK, and Royal Society of Chemistry are 5 of 9 investors who have invested in Refeyn.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process